Skip to content

Genome Analysis Across Populations in Inflammatory Bowel Disease

Healthy | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Objective:

To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined)
* Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U))
* Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss
* Any age

Exclusion Criteria:

\- Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria

Study Location

Sinai Health System
Sinai Health System
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Joanne Stempak, MSc

[email protected]
4165864800
Study Sponsored By
Mount Sinai Hospital, Canada
Participants Required
More Information
Study ID: NCT06042387